Literature DB >> 19489954

Effects of cytomegalovirus infection on embryogenesis and brain development.

Yoshihiro Tsutsui1.   

Abstract

Congenital cytomegalovirus (CMV) infection is a significant cause of brain disorders, such as microcephaly, mental retardation, hearing loss and visual disorders in humans. The type and severity of brain disorder may be dependent on the stage of embryonic development when the congenital infection occurs. Developmental disorders may be associated with the type of embryonic cells to which CMV is susceptible and the effects of the infection on the cellular functions of these cells. Early murine embryos, including embryonic stem (ES) cells, are not susceptible to CMV infection. A part of the embryonic cells acquire susceptibility during early development. Mesenchymal cells are the targets of infection at midgestation, affecting organogenesis of the brain, eyes and oral-facial regions. In contrast to ES cells, neural stem progenitor cells (NSPC) from fetal brains are susceptible to murine CMV (MCMV) infection. The viral infection inhibits proliferation and differentiation of the NSPC to neuronal and glial cells in addition to induction of neuronal cell loss. These cellular events may cause brain malformations, such as microcephaly and polymicrogyria. Furthermore, MCMV persists in neuronal cells in developing brains, presumably resulting in neuronal dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19489954     DOI: 10.1111/j.1741-4520.2009.00222.x

Source DB:  PubMed          Journal:  Congenit Anom (Kyoto)        ISSN: 0914-3505            Impact factor:   1.409


  22 in total

1.  Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.

Authors:  Sara Ornaghi; Lawrence S Hsieh; Angélique Bordey; Patrizia Vergani; Michael J Paidas; Anthony N van den Pol
Journal:  J Neurosci       Date:  2017-06-19       Impact factor: 6.167

2.  High-resolution crystal structures of two prototypical β- and γ-herpesviral nuclear egress complexes unravel the determinants of subfamily specificity.

Authors:  Yves A Muller; Sigrun Häge; Sewar Alkhashrom; Tobias Höllriegl; Sebastian Weigert; Simon Dolles; Kerstin Hof; Sascha A Walzer; Claudia Egerer-Sieber; Marcus Conrad; Stephanie Holst; Josephine Lösing; Eric Sonntag; Heinrich Sticht; Jutta Eichler; Manfred Marschall
Journal:  J Biol Chem       Date:  2020-01-24       Impact factor: 5.157

3.  Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA.

Authors:  Jean-Philippe Belzile; Thomas J Stark; Gene W Yeo; Deborah H Spector
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

4.  Effects of cytomegalovirus infection in human neural precursor cells depend on their differentiation state.

Authors:  H M González-Sánchez; A Monsiváis-Urenda; C A Salazar-Aldrete; A Hernández-Salinas; D E Noyola; M E Jiménez-Capdeville; A Martínez-Serrano; C G Castillo
Journal:  J Neurovirol       Date:  2015-04-08       Impact factor: 2.643

5.  Anti-viral effects of urosolic acid on guinea pig cytomegalovirus in vitro.

Authors:  Jingjing Zhao; Juanjuan Chen; Tao Liu; Jianguo Fang; Jin Wan; Jianhua Zhao; Wei Li; Jing Liu; Xianzhe Zhao; Suhua Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

6.  Impact of a cytomegalovirus kinase inhibitor on infection and neuronal progenitor cell differentiation.

Authors:  Tarin M Bigley; Jered V McGivern; Allison D Ebert; Scott S Terhune
Journal:  Antiviral Res       Date:  2016-02-11       Impact factor: 5.970

Review 7.  Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model.

Authors:  Irena Slavuljica; Daria Kveštak; Peter Csaba Huszthy; Kate Kosmac; William J Britt; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2014-07-21       Impact factor: 11.530

8.  Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection.

Authors:  Xing Pan; Xiao-Jun Li; Xi-Juan Liu; Hui Yuan; Jia-Fu Li; Ying-Liang Duan; Han-Qing Ye; Ya-Ru Fu; Guan-Hua Qiao; Cong-Cong Wu; Bo Yang; Xiao-Hui Tian; Kang-Hong Hu; Ling-Feng Miao; Xiao-Ling Chen; Jun Zheng; Simon Rayner; Philip H Schwartz; William J Britt; Jiang Xu; Min-Hua Luo
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

9.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

10.  Mood stabilizers inhibit cytomegalovirus infection.

Authors:  Sara Ornaghi; John N Davis; Kelly L Gorres; George Miller; Michael J Paidas; Anthony N van den Pol
Journal:  Virology       Date:  2016-09-19       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.